Center for Outcomes Research and Evaluation, Yale New Haven Health, New Haven, CT, USA.
Academic Group of Clinical Epidemiology, School of Medicine, University of Antioquia, Medellín, Colombia.
Yale J Biol Med. 2019 Dec 20;92(4):629-640. eCollection 2019 Dec.
Sepsis is a highly complex and lethal syndrome with highly heterogeneous clinical manifestations that makes it difficult to detect and treat. It is also one of the major and most urgent global public health challenges. More than 30 million people are diagnosed with sepsis each year, with 5 million attributable deaths and long-term sequalae among survivors. The current international consensus defines sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to an infection. Over the past decades substantial research has increased the understanding of its pathophysiology. The immune response induces a severe macro and microcirculatory dysfunction that leads to a profound global hypoperfusion, injuring multiple organs. Consequently, patients with sepsis might present dysfunction of virtually any system, regardless of the site of infection. The organs more frequently affected are kidneys, liver, lungs, heart, central nervous system, and hematologic system. This multiple organ failure is the hallmark of sepsis and determines patients' course from infection to recovery or death. There are tools to assess the severity of the disease that can also help to guide treatment, like the Sequential Organ Failure Assessment (SOFA) score. However, sepsis disease process is vastly heterogeneous, which could explain why interventions targeted to directly intervene its mechanisms have shown unsuccessful results and predicting outcomes with accuracy is still elusive. Thus, it is required to implement strong public health strategies and leverage novel technologies in research to improve outcomes and mitigate the burden of sepsis and septic shock worldwide.
脓毒症是一种高度复杂且致命的综合征,临床表现高度异质,难以检测和治疗。它也是主要的、最紧迫的全球公共卫生挑战之一。每年有超过 3000 万人被诊断患有脓毒症,其中 500 万人死亡,幸存者有长期后遗症。目前国际共识将脓毒症定义为宿主对感染的失调反应引起的危及生命的器官功能障碍。在过去的几十年中,大量的研究增加了对其病理生理学的理解。免疫反应引起严重的宏观和微循环功能障碍,导致广泛的低灌注,损伤多个器官。因此,脓毒症患者可能表现出几乎任何系统的功能障碍,而与感染部位无关。更常受影响的器官是肾脏、肝脏、肺、心脏、中枢神经系统和血液系统。这种多器官衰竭是脓毒症的标志,并决定了患者从感染到恢复或死亡的病程。有一些工具可以评估疾病的严重程度,也可以帮助指导治疗,例如序贯器官衰竭评估(SOFA)评分。然而,脓毒症的疾病过程是高度异质的,这可以解释为什么针对其机制的干预措施没有取得成功的结果,并且准确预测结果仍然难以实现。因此,需要实施强有力的公共卫生策略,并利用研究中的新技术来改善全球脓毒症和脓毒性休克的结局并减轻其负担。